Medications
GSK says sells thrombosis brands, French site
British drugs firm GlaxoSmithKline (GSK) said Monday that it has sold two thrombosis brands and a French plant to South African peer Aspen for £700 million ($1.13 billion, 834 million euros).
Sep 30, 2013
0
0
